Pay in 4 interest-free payments of $42.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
thus avoiding estrogenic side effects
Comprehensive documentation
lower inflammation
bone density
people taking higher doses (up to 12mg) lost an average of 24% of their body weight over 48 weeks
Klow - GHK-Cu (50 mg) / BPC-157 (10 mg) / TB-500 (10 mg) / and KPV (10 mg) Quantity:1 vial thus avoiding estrogenic side effectsKLOW is a research peptide blend combining four peptidesGHK Cu (50 mg), BPC 157 (10 mg), TB 500 (10 mg), and KPV (10 mg)in an 80 mg formulation designed for synergistic effects in preclinical studies. Unlike Semaglutide, Tirzepatide, and Retatrutide, which are incretin based therapies targeting GLP 1, GIP, and or glucagon receptors for diabetes and weight management, KLOW focuses on tissue repair, inflammation control, and cellular regeneration. GHK
US$ 17.00
US$ 59.00
US$ 90.00
US$ 17.00
